Download - Podium Session 13

Transcript
Page 1: Podium Session 13

Monday, May 6, 1996 Podium Session 13 1:00 pm to 2:55 pm J

SOCIETY OF UROLOGIC ONCOLOGY Hall F, Orange County Convention Center

Moderators: Wil l iam J. Catalona, St. Louis, M O Joseph A. Smith, Jr., Nashville, TN

(Note: all presentations are 7 minutes in length.)

1:00

1:35

1:45

1:55

2:05

1996 WILLET WHITMORE, JR., M.D. LECTURE: Cloning Cancer Susceptibility Genes.

Mark Skolnick. Sponsored by Society of Urologic Oncology

#503 Prostate specific gene therapy using a novel PSA promoter: in vivo studies.

John Franklin, Shen Pang, Charles Sawyer, Randhir Kaboo, Cho-Lee Tso, Jean deKernion and Arie Belldegrun, Los Angeles, CA (Presented by Dr. Franklin).

#504 Effectiveness of prostasure in detecting prostate cancer (PCa) and benign prostatic hyperplasia (BPH) in men age 50 and older.

Thomas A. Stamey, Stephen D. Barnhill, Zhen Zhang, K.R. Madyastha, Anthony F. Prestigiacomo, Kerrie Jones and Daniel Chan, Stanford, CA (Presented by Dr. Stamey).

#505 Enhanced RT-PCR for PSA offers unique prog- nostic information during androgen deprivation therapy.

Mitchell C. Benson, Glen de Vries, Aaron E. Katz, Carl A. Olsson and Ralph E. Buttyan, New York, NY (Presented by Dr. Benson).

#506 Quality of life after salvage cryotherapy for locally recurrent prostate cancer.

Andrew C. yon Eschenbach, Shellie M. Scott, David A. Swanson, Richard J. Babaian, Colin P.N. Dinney, Curtis A. Pettaway and Louis L. Pisters, Houston, TX (Presented by Dr. Pisters).

2:15 #507

2:25

2:35

2:45

#508

#509

#510

Five-year follow-up of a prospective trial of radi- cal cystectomy and neoadjuvant chemotherapy. Nordic cystectomy trial 1.

Per-Uno Malmstr/~m, Erkki Rintala, Rolf Wahlqvist, Pekka Hellstr6m, Sverker Hellsten and Einar Hannisdal, Uppsala, Sweden (Presented by Dr. Malmstr6m).

Does the option of the ileal neobladder stimulate patient and physician decision towards earlier cystectomy?

Richard E. Hautmann and Thomas Paiss, UIm, Germany (Presented by Dr Hautmann).

The von HippeI-Lindau tumor suppressor gene protein product (pVHL) binds to the transcrip- tion factors, elongin B and C.

Adam S. Kibel, Othon lliopoulos, James A. DeCaprio, Jerome P. Richie and William G. Kaelin, Boston, MA (Presented by Dr. Kibel).

Patterns of tumor recurrence and guidelines for follow-up after nephron-sparing surgery for renal cell carcinoma.

Khaled Hafez, Andrew C. Novick and Stephen C. Campbell, Cleveland, OH (Presented by Dr. Hafez).

126

Top Related